Picture of Biotoxtech Co logo

086040 Biotoxtech Co Income Statement

0.000.00%
kr flag iconLast trade - 00:00
HealthcareAdventurousMicro CapSucker Stock

Annual income statement for Biotoxtech Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

2019
December 31st
2020
December 31st
R2021
December 31st
2022
December 31st
2023
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:Annual Audited AccountsAnnual Audited AccountsAnnual Audited AccountsAnnual Audited AccountsAnnual Audited Accounts
Standards:
IFRS
IFRS
IFRS
IFRS
IFRS
Status:FinalFinalFinalFinalFinal
Revenue
Total Revenue25,85426,42932,71737,29232,631
Cost of Revenue
Gross Profit5,3706,43610,54612,4801,899
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Unusual Expense / Income
Total Operating Expenses25,98525,89128,08636,31240,855
Operating Profit-1315374,632979-8,224
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes-1,7223,2456,485-644-11,833
Provision for Income Taxes
Net Income After Taxes-1,6052,3676,69864.7-8,950
Minority Interest
Net Income Before Extraordinary Items
Extraordinary Items
Net Income-1,5822,6147,1142,725-4,878
Adjustments to Net Income
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Dilution Adjustment
Diluted Net Income-1,5822,6147,1142,725-4,878
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS-10318044682.9-314
Dividends per Share